LetermovirLack of efficacy and off-label use : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2019卷 / 1期

关键词：

D O I：

10.1007/s40278-024-64155-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[21] DenosumabLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1909 (1) : 216 - 216
[22] NifedipineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 386 - 386
[23] TocilizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1954 (1) : 409 - 409
[24] RituximabLack of efficacy in off-label use: case report
Reactions Weekly, 2023, 1946 (1) : 492 - 492
[25] OsimertinibLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1949 (1) : 349 - 349
[26] IdebenoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1929 (1) : 335 - 335
[27] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1951 (1) : 49 - 49
[28] RanibizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2040 (1) : 860 - 860
[29] AntiviralsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1976 (1) : 48 - 48
[30] AntibacterialsLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1920 (1) : 43 - 43

← 1 2 3 4 5 →